Eelke Brandsma

PostDoc
Department of Hematopoiesise, Sanquin Research, Amsterdam, The Netherlands

Presentation(s):

• PB0185 - Exploring red blood cells as a novel tolerogenic approach for factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM